Zydus’ Nesher Pharma Gets USFDA Nod

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final approval from USFDA to market Dextroamphetamine Sulfate extended-release capsules, 5 mg.

The drug will be produced at the Nesher Pharmaceuticals manufacturing facility located at St. Loius, US.

Dextroamphetamine is central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD) and in the treatment of narcolepsy (a type of sleep disorder).

The group has now more than 120 approvals and has so far filed over 300 ANDAs, since the commencement of the filing process in FY 2003-04.

Cadila Healthcare Limited is an India-based pharmaceutical company. The company’s subsidiaries include Zydus Wellness Limited, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited and German Remedies Limited etc. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.co
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔
Give a Missed Call for Free Trial - 09699997717 ✔

Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.